# Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

> **NCT00028938** · PHASE3 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 1 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **BIOLOGICAL:** epoetin alfa
- **DRUG:** carboplatin
- **DRUG:** paclitaxel
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00028938
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01-01
- **Primary completion:** 2002-11-10
- **Final completion:** 2002-11-10
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2021-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00028938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00028938, "Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00028938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*